Extract:
Based on this comprehensive report published by Gravitas Market Insights, the Digital Therapeutics market is said to witness a significant growth during the forecast years between 2021 and 2028. Digital therapeutics is a subcategory of digital health; however, not all digital health solutions are also digital therapeutics. The distinction between digital health and digital medicines is determined by patient clinical outcomes. Consumer health-oriented devices such as step-counters and calorie-counters, for example, are not included in digital therapies. The Digital Therapeutics market is observing a huge demand ever since the COVID-19 pandemic has struck. This surge is likely to stay constant and for the next couple of years and will begin to normalize post 2022.
Report Scope in detail:
This latest report edition of Digital Therapeutics market has been added to our huge database of detailed reports and this envisions to shape the future of all the related businesses. Our team of learned research analysts have studied in-depth and curated the report based on several aspects which include the overview of the market, driving forces, growth rate, market trends, market size, opportunities and challenges of the market; along with detailed competitive analysis on the regional as well as global level. The Digital Therapeutics market research report renders a thorough analysis of the market on a global aspect and aims on several market segmentation. This report also provides deeper perception into the latest trends of the market and pinpoints crucial product developments of the industry. Furthermore, the report collects numerous factors that have accredited to the growth of the market in the recent years.
Market Dynamics:
- The adoption of smartphones and tablets, along with healthcare apps, is increasing, as is the desire to control healthcare expenses.
- There is also an increase in the incidence of chronic diseases, all of which are driving demand for global digital treatments. However, in poorer nations, a lack of awareness of digital therapeutics and worries about patient data protection are limiting market expansion.
- For producers in the digital therapeutics business, high growth potential in undeveloped markets are likely to bring significant profit opportunities.
- In 2019, North America dominated the market, accounting for the largest share, and this trend is expected to continue throughout the projected period.
Digital Therapeutics Market Segmentation:
By Application
- Chronic Respiratory Disorders
- Cardiovascular Diseases
- Diabetes
- Musculoskeletal Disorders
- Gastrointestinal Disorders
- Medication Adherence
- Rehabilitation & Patient Care
- Lifestyle Management
- Others
By End User
- Healthcare Service Providers
- Patients
- Clinicians
- Others
Regional Coverage
- North America
- United States
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Korea
- Australia
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Colombia
- Rest of South America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Competitive Analysis:
Eminent market players have been outlined in order to extract improved insights into the worldwide businesses. Our research reports offer all-inclusive information on various top most manufacturers that are operational across global regions. We provide company profiles which include detailed overview of the company, business information, business performance, crucial strategies implemented through the years.
Few of the Key Players Covered in Our Report:
- Proteus Digital Health
- Omada Health
- WellDoc
- Propeller Health
- Happify
- Wellthy Therapeutics
- Pear Therapeutics
- Akili Interactive Labs
- Better Therapeutics
- Click Therapeutics
- Cognoa
- Mindstrong Health
Impact of COVID19:
The COVID19 pandemic crippled the global economy, it resulted in a worldwide lockdown and this has majorly impacted numerous industries. Our industry experts are working round-the-clock to identify, accumulate and in-time deliver market analysis due to the effect of unprecedented decisions in COVID-19 repercussions on many businesses. The full version of this report will comprise the overall impact of the pandemic, and predicted alteration on the future outlook of the industry, by taking into the account the economic, political, technological and social parameters.
This research study involves broad usage of both secondary and primary data sources. The research process involves the identification of numerous factors which affect the industry, comprising the market environment, government policy, historical data, present trends in the market, competitive landscape, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges.
Market Estimation
Top-down and bottom-up approaches are used for validating the market size for companies, regional segments along with relevant market segmentations such as product type and application.
This report includes market estimations which are based on the marketed sale price of a product. Further breakdown of product segments, particular market share are formed based on the weightage assigned to every segment, which is derived of their usage rate and average price. The entire probable factors which effect the markets and influence them in a great way are included in this research report; and have been accounted for, studied in-depth and are confirmed through primary research. These are then studies to get the final qualitative and quantitative data. Any of the factors such as the outcome of inflation, economic downfall, and any kind of policy and regulatory alterations and/or other such factors are not accounted for in the market forecast. All of this data is amalgamated and included with thorough inputs and analysis from Gravitas Market Insights is curated in this report.
Along with the previously mentioned approaches, various data triangulation methods, in order to conduct market estimations and market forecasting for the complete market segments are detailed in this report. Key Companies present in the said market are also acknowledged via in-depth secondary research and primary research.
Section 1: Executive Summary
1.1. Digital Therapeutics Market Industry 360° outline, Year 2016 – 2028
1.2. Business Model Trends
1.3. Growth Trends
1.4. End-User/End User Trends
1.5. Regional Trends
Section 2: Market Dynamics - Digital Therapeutics Market Industry Insights
2.1. Growth Drivers
2.2. Opportunities
2.3. Industry challenges
2.4. SWOT Analysis
2.5. Porter’s Analysis
2.6. Worldwide Industry Landscape, Year 2016 – 2028
2.7. Industry Segmentation
2.8. Technology & Invention landscape
2.9. Regional Landscape
2.9.1. North America
2.9.2. Europe
2.9.3. Asia-Pacific
2.9.4. South America
2.9.5. Middle East & Africa
2.10. Competitive Environment
Section 3: Global Digital Therapeutics Market, By Application
3.1. Segmentation Analysis, By Application, 2016-2028
3.2. Market Share Segmentation Analysis, By Application, 2016-2028
3.3. Chronic Respiratory Disorders
3.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
3.4. Cardiovascular Diseases
3.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
3.5. Diabetes
3.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
3.6. Musculoskeletal Disorders
3.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
3.7. Gastrointestinal Disorders
3.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
3.8. Medication Adherence
3.8.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
3.9. Rehabilitation & Patient Care
3.9.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
3.10. Lifestyle Management
3.10.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
3.11. Others
3.11.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
Section 4: Global Digital Therapeutics Market, By End User
4.1. Segmentation Analysis, By End User, 2016-2028
4.2. Market Share Segmentation Analysis, By End User, 2016-2028
4.3. Healthcare Service Providers
4.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
4.4. Patients
4.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
4.5. Clinicians
4.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
4.6. Others
4.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
Section 5: Global Digital Therapeutics Market, Regional Analysis
5.1. Global Digital Therapeutics Market, Regional Analysis
5.2. North America, Country level Analysis
5.2.1. North America Digital Therapeutics Market estimates and forecast with Growth rate analysis, By Application, 2016 – 2028
5.2.2. North America Digital Therapeutics Market estimates and forecast with Growth rate analysis, By End User, 2016 – 2028
5.2.3. United States
5.2.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.2.4. Canada
5.2.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.2.5. Mexico
5.2.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.3. Europe Country level Analysis
5.3.1. Europe Digital Therapeutics Market estimates and forecast with Growth rate analysis, By Application, 2016 – 2028
5.3.2. Europe Digital Therapeutics Market estimates and forecast with Growth rate analysis, By End User, 2016 – 2028
5.3.3. UK
5.3.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.3.4. Germany
5.3.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.3.5. France
5.3.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.3.6. Italy
5.3.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.3.7. Spain
5.3.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.3.8. Russia
5.3.8.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.3.9. Rest of Europe
5.3.9.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.4. Asia-Pacific Country level Analysis
5.4.1. Asia-Pacific Digital Therapeutics Market estimates and forecast with Growth rate analysis, By Application, 2016 – 2028
5.4.2. Asia-Pacific Digital Therapeutics Market estimates and forecast with Growth rate analysis, By End User, 2016 – 2028
5.4.3. China
5.4.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.4.4. India
5.4.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.4.5. Japan
5.4.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.4.6. Korea
5.4.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.4.7. Australia
5.4.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.4.8. Southeast Asia
5.4.8.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.4.9. Rest of Asia-Pacific
5.4.9.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.5. South America Country level Analysis
5.5.1. South America Digital Therapeutics Market estimates and forecast with Growth rate analysis, By Application, 2016 – 2028
5.5.2. South America Digital Therapeutics Market estimates and forecast with Growth rate analysis, By End User, 2016 – 2028
5.5.3. Brazil
5.5.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.5.4. Argentina
5.5.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.5.5. Colombia
5.5.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.5.6. Rest of South America
5.5.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.6. Middle East & Africa Country level Analysis
5.6.1. MEA Digital Therapeutics Market estimates and forecast with Growth rate analysis, By Application, 2016 – 2028
5.6.2. MEA Digital Therapeutics Market estimates and forecast with Growth rate analysis, By End User, 2016 – 2028
5.6.3. GCC
5.6.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.6.4. South Africa
5.6.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.6.5. Rest of Middle East & Africa
5.6.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
Section 6: Company Profile - Digital Therapeutics Market
6.1. Proteus Digital Health
6.1.1. Business Overview
6.1.2. Product & Service Offering
6.1.3. Overall Revenue
6.1.4. Strategic Outlook
6.2. Omada Health
6.2.1. Business Overview
6.2.2. Product & Service Offering
6.2.3. Overall Revenue
6.2.4. Strategic Outlook
6.3. WellDoc
6.3.1. Business Overview
6.3.2. Product & Service Offering
6.3.3. Overall Revenue
6.3.4. Strategic Outlook
6.4. Propeller Health
6.4.1. Business Overview
6.4.2. Product & Service Offering
6.4.3. Overall Revenue
6.4.4. Strategic Outlook
6.5. Happify
6.5.1. Business Overview
6.5.2. Product & Service Offering
6.5.3. Overall Revenue
6.5.4. Strategic Outlook
6.6. Wellthy Therapeutics
6.6.1. Business Overview
6.6.2. Product & Service Offering
6.6.3. Overall Revenue
6.6.4. Strategic Outlook
6.7. Pear Therapeutics
6.7.1. Business Overview
6.7.2. Product & Service Offering
6.7.3. Overall Revenue
6.7.4. Strategic Outlook
6.8. Akili Interactive Labs
6.8.1. Business Overview
6.8.2. Product & Service Offering
6.8.3. Overall Revenue
6.8.4. Strategic Outlook
6.9. Better Therapeutics
6.9.1. Business Overview
6.9.2. Product & Service Offering
6.9.3. Overall Revenue
6.9.4. Strategic Outlook
6.10. Click Therapeutics
6.10.1. Business Overview
6.10.2. Product & Service Offering
6.10.3. Overall Revenue
6.10.4. Strategic Outlook
6.11. Cognoa
6.11.1. Business Overview
6.11.2. Product & Service Offering
6.11.3. Overall Revenue
6.11.4. Strategic Outlook
6.12. Mindstrong Health
6.12.1. Business Overview
6.12.2. Product & Service Offering
6.12.3. Overall Revenue
6.12.4. Strategic Outlook
*Market size and forecast will be provided from 2016-2028, and forecast period would be 2021-2028
*Details on financial performance and strategic moves and developments may not be captured for unlisted companies
*List of companies profiled in this TOC is tentative and may change after detailed analysis
